Works by Ravindranath, Mepur H.


Results: 26
    1
    2
    3

    Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.

    Published in:
    Cancer (0008543X), 2000, v. 88, n. 8, p. 1828, doi. 10.1002/(SICI)1097-0142(20000415)88:8<1828::AID-CNCR11>3.0.CO;2-F
    By:
    • Chu, Kyo U.;
    • Ravindranath, Mepur H.;
    • Gonzales, Alexandra;
    • Nishimoto, Kevin;
    • Tam, Wai Yin;
    • Soh, Daniel;
    • Bilchik, Anton;
    • Katopodis, Nonda;
    • Morton, Donald L.
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    12

    Ratio of IgG: IgM antibodies to sialyl Lewis.

    Published in:
    International Journal of Cancer, 1998, v. 75, n. 1, p. 117, doi. 10.1002/(SICI)1097-0215(19980105)75:1<117::AID-IJC18>3.0.CO;2-D
    By:
    • Ravindranath, Mepur H.;
    • Kelley, Mark C.;
    • Jones, Ralph C.;
    • Amiri, Amir A.;
    • Bauer, Philip M.;
    • Morton, Donald L.
    Publication type:
    Article
    13
    14
    15

    Human Antiganglioside Autoantibodies: Validation of ELISA.

    Published in:
    Annals of the New York Academy of Sciences, 2005, v. 1050, n. 1, p. 229, doi. 10.1196/annals.1313.024
    By:
    • RAVINDRANATH, MEPUR H.;
    • MUTHUGOUNDER, SAKUNTHALA;
    • SARAVANAN, THIRUVERKADU S.;
    • PRESSER, NAFTALI;
    • MORTON, DONALD L.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26